Literature DB >> 24130206

Transient bradycardia induced by thiopentone sodium: a unique challenge in the management of refractory status epilepticus.

Sushma Sharma1, Pradeep P Nair, Aditya Murgai, Raja J Selvaraj.   

Abstract

Thiopentone sodium is one of the important drugs in the armamentarium for terminating refractory status epilepticus, a neurological emergency. We report a case of thiopentone-related bradycardia during the management of the new onset refractory status epilepticus in a young man, which was circumvented by prophylactic insertion of temporary pacemaker while thiopentone infusion was continued. A systematic approach was employed to manage the status epilepticus, including infusion of thiamine and glucose followed by antiepileptic drugs. The patient was ventilated and infused with lorazepam, phenytoin, sodium valproate, levetiracetam and midazolam followed by thiopentone sodium. With the introduction of thiopentone the seizures could be controlled but the patient developed severe bradycardia and junctional rhythm. The bradycardia disappeared when thiopentone was withdrawn and reappeared when the drug was reintroduced. Propofol infusion was tried with no respite in seizures. Later thiopentone sodium was reintroduced after inserting temporary cardiac pacemaker. Seizure was controlled and patient was weaned off the ventilator.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24130206      PMCID: PMC3822096          DOI: 10.1136/bcr-2013-200484

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  The management of status epilepticus.

Authors:  S Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

2.  Human cardiac sodium channels are affected by pentobarbital.

Authors:  H C Wartenberg; J P Wartenberg; B W Urban
Journal:  Eur J Anaesthesiol       Date:  2001-05       Impact factor: 4.330

3.  The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists.

Authors:  M Holtkamp; F Masuhr; L Harms; K M Einhäupl; H Meierkord; K Buchheim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

4.  Complications and side effects during thiopentone therapy in patients with severe head injuries.

Authors:  W Schalén; K Messeter; C H Nordström
Journal:  Acta Anaesthesiol Scand       Date:  1992-05       Impact factor: 2.105

5.  The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity.

Authors:  E P V Wilder-Smith; E C H Lim; H L Teoh; V K Sharma; J J H Tan; B P L Chan; B K C Ong
Journal:  Ann Acad Med Singap       Date:  2005-08       Impact factor: 2.473

6.  EFNS guideline on the management of status epilepticus in adults.

Authors:  H Meierkord; P Boon; B Engelsen; K Göcke; S Shorvon; P Tinuper; M Holtkamp
Journal:  Eur J Neurol       Date:  2009-12-30       Impact factor: 6.089

7.  Sequential occurrence of life-threatening hypokalemia and rebound hyperkalemia associated with barbiturate coma therapy.

Authors:  J Y Jung; C Lee; H Ro; H S Kim; K W Joo; Y Kim; C Ahn; J S Han; S Kim; K-H Oh
Journal:  Clin Nephrol       Date:  2009-03       Impact factor: 0.975

8.  Prognosis and natural history of drug-related bradycardia.

Authors:  Jang Hoon Lee; Hyeon Min Ryu; Myung Hwan Bae; Yong Seop Kwon; Ju Hwan Lee; Yongwhi Park; Jung-Ho Heo; Young Soo Lee; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung Chull Chae; Yoon-Nyun Kim; Jae-Eun Jun; Wee-Hyun Park
Journal:  Korean Circ J       Date:  2009-09-30       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.